In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses

In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses

Background/Aims As the coronavirus disease-2019 global pandemic progresses, screening of antiviral agents effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is urgently needed. In addition, considering the viral load kinetics of SARS-CoV-2, which peaks early in the illnes...

Full description

Bibliographic Details
Main Authors: Chang Kyung Kang, Moon-Woo Seong, Su-Jin Choi, Taek Soo Kim, Pyoeng Gyun Choe, Sang Hoon Song, Nam-Joong Kim, Wan Beom Park, Myoung-don Oh
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2020-07-01
Series:The Korean Journal of Internal Medicine
Subjects:
covid-19
severe acute respiratory syndrome coronavirus 2
in vitro techniques
lopinavir/ritonavir
hydroxychloroquine
Online Access:http://www.kjim.org/upload/pdf/kjim-2020-157.pdf

Internet

http://www.kjim.org/upload/pdf/kjim-2020-157.pdf

Similar Items